Expression of Erbin in esophageal squamous cell carcinoma and its relationship with patient prognosis
10.3969/j.issn.1000-8179.2019.12.365
- VernacularTitle:Erbin在食管鳞状细胞癌中的表达及其与患者预后的关系*
- Author:
Luyao WANG
1
,
2
;
Jiale YU
;
Shuaiying LIU
;
Caifeng DONG
;
Chunying BAI
;
Junyi ZHANG
Author Information
1. 锦州医科大学赤峰学院研究生培养基地(内蒙古自治区赤峰市024000)
2. 赤峰学院附属医院皮肤科
- Keywords:
Erbin;
esophageal squamous cell carcinoma;
prognosis
- From:
Chinese Journal of Clinical Oncology
2019;46(12):595-600
- CountryChina
- Language:Chinese
-
Abstract:
To explore the significance of Erbin expression in esophageal squamous cell carcinoma (ESCC) and its relation-ship with patient prognosis. Methods: Erbin expression in a tissue chip containing samples from 299 cases were examined using immu-nohistochemistry; in addition, the relationship between Erbin expression and clinical-pathological parameters and patient survival time were also analyzed. Cox regression was used to predict the risk of clinical-pathological parameters. The mRNA and protein expres-sion of Erbin was also determined in 25 cases with paired ESCC and normal tissues through polymerase chain reaction (PCR) and West-ern blot. Results: The expression of Erbin protein and mRNA in ESCC were significantly higher than those of normal esophageal epithe-lium adjacent to cancer (55.2% vs. 0, P<0.05). The high expression of Erbin in ESCC was closely related to TNM stage (64.9% vs. 47.3%, P=0.002) and lymph node metastasis (65.5% vs. 45.0%, P<0.001). Moreover, the high expression of Erbin in ESCC was closely related to poor prognosis (P<0.05). Conclusions: Erbin expression was increased in ESCC and was closely related to poor patient prognosis, which suggested that Erbin may be an important biomarker for the prognosis of cancer patients.
